Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.

< BACK TO ARCHIVE


2022 Apr 08


J Clin Lab Anal


http://www.ncbi.nlm.nih.gov/pubmed/35396748?dopt=Abstract

Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.

Authors

Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.
Koupaei M, Mohamadi M H, Yashmi I, Shahabi A H, Shabani A H, Heidary M, Khoshnood S
J Clin Lab Anal. 2022 Apr 08:e24402.
PMID: 35396748.

Abstract

Interest revolving around coronavirus disease 2019 (COVID-19) reinfection is escalating rapidly. By definition, reinfection denotes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), PCR redetection, and COVID-19 recurrence within three months of the initial symptoms. The main aim of the current systematic review was to evaluate the features of COVID-19 relapse patients.
Read This Paper